Conrad, Amy L.
DeMauro, Sara B.
Kirpalani, Haresh
Ziolkowski, Kristina
Hintz, Susan R.
Vohr, Betty R.
Watson, Victoria
Colaizy, Tarah T.
Bell, Edward F.
Brumbaugh, Jane E.
Bann, Carla M.
Tan, Sylvia M.
Newman, Jamie E.
Das, Abhik
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (UG3HL143204, U24HL143216, UG3HL143204, U24HL143216, UG3HL143204, U24HL143216, UG3HL143204, U24HL143216, UG3HL143204, U24HL143216, UG3HL143204, U24HL143216, UG3HL143204, U24HL143216, UG3HL143204, U24HL143216, UG3HL143204, U24HL143216, UG3HL143204, U24HL143216, UG3HL143204, U24HL143216, UG3HL143204, U24HL143216, UG3HL143204, U24HL143216, UG3HL143204, U24HL143216)
Article History
Received: 21 February 2025
Accepted: 5 May 2025
First Online: 15 May 2025
Declarations
:
: The TOP 5 Study was approved by the local IRB at each participating center and written informed consent to participate was provided by a parent or legal guardian of each child.IRB reference numbers for each participating center are:
: Not applicable. Results of the TOP 5 Study will be shared at a major academic pediatric meeting and then submitted to a peer-reviewed medical journal as soon as possible after completion of the study. All members of the study subcommittee will be named as authors on the primary study publication, given their contributions throughout the conduct of the study, as long as they meet ICJME authorship criteria at the time of publication. No professional writers will be used. Results will also be shared with the families of study participants through a paper mail or e-mail study newsletter.
: The authors declare no competing interests.